Abstract
We present a case of idiopathic orbital inflammatory disease that was responded favorably to low-dose cyclosporine-A.
ACKNOWLEDGMENTS
Dr. Zacharopoulos is the recipient of the postgraduate fellowship of the Embeirikeion Foundation, Greece
Declaration of Interest: None of the authors has any financial interest related to this article.